KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Castle Biosciences (CSTL) Inventory (2018 - 2025)

Historic Inventory for Castle Biosciences (CSTL) over the last 8 years, with Q3 2025 value amounting to $8.6 million.

  • Castle Biosciences' Inventory rose 3161.9% to $8.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.6 million, marking a year-over-year increase of 3161.9%. This contributed to the annual value of $8.1 million for FY2024, which is 243.01% up from last year.
  • Castle Biosciences' Inventory amounted to $8.6 million in Q3 2025, which was up 3161.9% from $8.4 million recorded in Q2 2025.
  • Castle Biosciences' 5-year Inventory high stood at $8.6 million for Q3 2025, and its period low was $2.0 million during Q4 2021.
  • In the last 5 years, Castle Biosciences' Inventory had a median value of $5.8 million in 2023 and averaged $5.3 million.
  • Per our database at Business Quant, Castle Biosciences' Inventory surged by 9954.77% in 2023 and then crashed by 1041.2% in 2025.
  • Quarter analysis of 5 years shows Castle Biosciences' Inventory stood at $2.0 million in 2021, then skyrocketed by 96.93% to $4.0 million in 2022, then surged by 99.55% to $7.9 million in 2023, then increased by 2.43% to $8.1 million in 2024, then grew by 6.33% to $8.6 million in 2025.
  • Its Inventory stands at $8.6 million for Q3 2025, versus $8.4 million for Q2 2025 and $6.8 million for Q1 2025.